Treatment with ulipristal acetate (Esmya(®)) and plasma levels of tacrolimus: a case report.
Department of Gynecology, University Hospital of Bellvitge, Barcelona, Spain. Electronic address: lfernandezdecastillo@bellvitgehospital.cat.
Luis
L
Fernández de Castillo Torras
Department of Gynecology, University Hospital of Bellvitge, Barcelona, Spain.
Alex
A
Biterna Tejeiro
Department of Gynecology, University Hospital of Bellvitge, Barcelona, Spain.
M Jesús
MJ
Pla Farnós
Department of Gynecology, University Hospital of Bellvitge, Barcelona, Spain.
Jordi
J
Ponce Sebastià
D000328:Adult; D002761:Cholangitis / Q000601:surgery; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007166:Immunosuppressive Agents / Q000097:blood* / Q000627:therapeutic use; D018231:Leiomyomatosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery; D016031:Liver Transplantation; D009173:Mycophenolic Acid / Q000627:therapeutic use; D009649:Norpregnadienes / Q000627:therapeutic use*; D016559:Tacrolimus / Q000097:blood* / Q000627:therapeutic use; D016896:Treatment Outcome; D014594:Uterine Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery
D007166:Immunosuppressive Agents; D009649:Norpregnadienes; D009173:Mycophenolic Acid; D016559:Tacrolimus; C555622:ulipristal acetate